Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
56.83
+0.08 (0.14%)
Dec 20, 2024, 4:00 PM EST - Market closed
Janux Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$83.09
Upside
+46.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +251.93% | Dec 11, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $42 → $62 | Hold | Maintains | $42 → $62 | +9.10% | Dec 4, 2024 |
| Stifel | Stifel | Strong Buy Maintains $70 → $115 | Strong Buy | Maintains | $70 → $115 | +102.36% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $79 → $91 | Buy | Maintains | $79 → $91 | +60.13% | Dec 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $63 → $70 | Strong Buy | Maintains | $63 → $70 | +23.17% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $79 | Buy | Initiates | $79 | +39.01% | Nov 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +10.86% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +75.96% | Nov 7, 2024 |
| UBS | UBS | Strong Buy Initiates $69 | Strong Buy | Initiates | $69 | +21.41% | Oct 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +75.96% | Sep 16, 2024 |
| Stifel | Stifel | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +23.17% | Sep 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +10.86% | Aug 19, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $47 → $42 | Hold | Maintains | $47 → $42 | -26.10% | Aug 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +75.96% | Aug 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $74 | Buy | Reiterates | $74 | +30.21% | Aug 8, 2024 |
| Scotiabank | Scotiabank | Hold Initiates $47 | Hold | Initiates | $47 | -17.30% | May 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.